A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy

Human Reproduction

Volumn 17, Issue 6, 2002, Pages 1477-1482

  Jain, John K ^a,d   Dutton, Caryn ^a   Harwood, Bryna ^b   Meckstroth, Karen R ^c   Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Abortion; Medical abortion; Mifepristone; Misoprostol; Pregnancy

Indexed keywords

LOPERAMIDE; MIFEPRISTONE; MISOPROSTOL; PARACETAMOL; PLACEBO; ABORTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTCOMES RESEARCH; PAIN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THERAPEUTIC ABORTION; CHEMICALLY INDUCED DISORDER; DRUG POTENTIATION; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; NAUSEA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0035988402     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.6.1477     Document Type: Article

References (19)

1. An effective regimen for early medical abortion: A report of 2000 consecutive cases
2. Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women
3. Termination of pregnancies of ≤6 weeks gestation with a single dose of 800 microg of vaginal misoprostol
4. The use of misoprostol for termination of early pregnancy
5. The use of misoprostol for abortion at ≤9 weeks' gestation
6. Drug therapy: Medical termination of pregnancy
7. Methotrexate and misoprostol for early abortion: A multicenter trial. I. Safety and efficacy
8. Mifepristone 100 mg in abortion regimens
9. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol
10. Early abortion with 800 micrograms of misoprostol by the vaginal route
11. Methotrexate and misoprostol to terminate early pregnancy
12. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: Historical comparison with mifepristone and oral misoprostol
13. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis
14. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: Efficacy and acceptability
15. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion
16. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days
17. Early pregnancy termination with mifepristone and misoprostol in the United States
18. Acceptability of medical abortion in early pregnancy
19. Absorption kinetics of misoprostol with oral or vaginal administration